journal
https://read.qxmd.com/read/38586205/lncrna-hoxa%C3%A2-as2-is-a-prognostic-and-clinicopathological-predictor-in-patients-with-cancer-a-meta%C3%A2-analysis
#41
JOURNAL ARTICLE
Tijun Xiao, An Yan, Lifang Tan, Hongwei Zhu, Wenzhe Gao
Elevated expression of long non-coding RNA homeobox A cluster antisense RNA 2 (lncRNA HOXA-AS2) is known to have prognostic value in various solid tumors. The present meta-analysis aimed to comprehensively quantify its prognostic significance across a wider spectrum of malignancies and to provide an updated synthesis of evidence that could refine prognostic models. To achieve this aim, multiple databases were carefully searched for lncRNA HOXA-AS2-related articles published in the past 10 years. Hazard ratios (HRs) or odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to demonstrate the prognostic value of lncRNA HOXA-AS2 using Stata 15...
May 2024: Oncology Letters
https://read.qxmd.com/read/38586204/simultaneous-blastic-plasmacytoid-dendritic-cell-neoplasm-and-myelofibrosis-a-case-report
#42
Fuyi Luo, Bingjie Li, Jing Li, Yan Li
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare and aggressive tumor with an unknown pathogenesis. Myelofibrosis (MF) is a type of myeloproliferative neoplasm. MF can be secondary to several hematological malignancies, including chronic myeloid leukemia, myelodysplastic syndrome and hairy cell leukemia. In the present report, a rare case of BPDCN secondary to MF is described. A 70-year-old male patient developed a large purplish-red rash with recurrent symptoms. BPDCN was confirmed by immunohistochemistry of a biopsy specimen and flow cytometry of bone marrow cells...
May 2024: Oncology Letters
https://read.qxmd.com/read/38586203/intrapleural-perfusion-hyperthermia-improves-the-efficiency-of-anti%C3%A2-pd1-antibody%C3%A2-based-therapy-for-lung-adenocarcinoma-a-case-report
#43
Xiaolei Wang, Jin Song, Ling Hu, Guanying Ren, Nan Geng, Zizheng Song
Chemotherapy based on intrapleural perfusion hyperthermia (IPH) can markedly improve the sensitivity of lung adenocarcinoma cells to anti-programmed cell death receptor 1 (PD1) antibody adjuvant chemotherapy and enhance the clinical response of a patient. In the present study, a unique case of a patient who failed to respond to immunotherapy combined with chemotherapy but achieved prolonged stable disease after treatment with IPH and subsequent sintilimab-based treatment, is reported. A 50-year-old Chinese female patient was admitted to a regional cancer hospital presenting with hemoptysis and persistent fever...
May 2024: Oncology Letters
https://read.qxmd.com/read/38586202/internal-mammary-node-abnormality-in-imaging-studies-and-treatment-outcomes-in-patients-with-breast-cancer
#44
JOURNAL ARTICLE
Kenji Makita, Yasushi Hamamoto, Hiromitsu Kanzaki, Kei Nagasaki, Kenjiro Aogi
The clinical significance of mild internal mammary node (IMN) enlargement (Mild-IMN) is uncertain. This study aimed to evaluate the relationship between treatment outcomes and IMN status in patients with breast cancer who underwent postmastectomy radiation therapy between January 2010 and December 2018. Overall, 250 patients were categorized based on IMN status: Clinically normal IMN (Normal-IMN; n=172), Mild-IMN (n=39) and clinically metastatic IMN (cMet-IMN; n=39). None of the patients in the Normal- or Mild-IMN groups received IMN irradiation...
May 2024: Oncology Letters
https://read.qxmd.com/read/38586201/-retracted-predictors-of-efficacy-of-anamorelin-in-patients-with-non%C3%A2-small-cell-lung-cancer-and-cachexia-a-retrospective-study
#45
Yoshiko Ishioka, Hisashi Tanaka, Tomonori Makiguchi, Syunsuke Fujishima, Yasuhito Nunomura, Hiroaki Sakamoto, Toshihiro Shiratori, Kageaki Taima, Sadatomo Tasaka
[This retracts the article DOI: 10.3892/ol.2023.14154.].
May 2024: Oncology Letters
https://read.qxmd.com/read/38586200/molecular-mechanism-of-formation-and-destruction-of-a-pseudo%C3%A2-capsule-in-clear-cell-renal-cell-carcinoma
#46
JOURNAL ARTICLE
Takuto Shimizu, Makito Miyake, Kota Iida, Sayuri Onishi, Tomomi Fujii, Yusuke Iemura, Kazuki Ichikawa, Chihiro Omori, Fumisato Maesaka, Mitsuru Tomizawa, Tatsuki Miyamoto, Nobumichi Tanaka, Kiyohide Fujimoto
The process and molecular mechanisms underlying the formation and destruction of a pseudo-capsule (PC) in clear cell renal cell carcinoma (ccRCC) are poorly understood. In the present study, the PCs of surgical specimens from primary tumors and metastatic lesions in 169 patients with ccRCC, and carcinogen-induced ccRCC rat models were semi-quantified using the invasion of PC (i-Cap) score system. This was based on the relationship among the tumor, PC and adjacent normal tissue (NT) as follows: i-Cap 0, tumor has no PC and does not invade NT; i-Cap 1, tumor has a complete PC and does not invade into the PC; i-Cap 2, tumor with focal absences in the PC, which partially invades the PC but not completely through the PC; i-Cap 3, tumor crosses the PC and invades the NT; i-Cap 4, tumor directly invades the NT without a PC...
May 2024: Oncology Letters
https://read.qxmd.com/read/38586199/diagnostic-value-of-hpv-e6-e7-mrna-in-screening-for-cervical-intraepithelial-neoplasia-grade-2-or-worse-a-systematic-review-and-meta%C3%A2-analysis
#47
JOURNAL ARTICLE
Fengsheng Xu, Tianfu Ran, Qiangang Wei, Rirun Pan, Shangzhong Chen, Jing Luo
Histology is considered the gold standard for diagnosing the pathological progress of cervical cancer development, while cervical intraepithelial neoplasia of grade 2 or worse (CIN2+) is the cutoff for intervention in clinical practice. The diagnostic value of human papillomavirus (HPV) E6/E7 mRNA in screening for CIN2+ has not been systematically summarized. A meta-analysis was conducted as part of the present study conducted to explore the diagnostic value of HPV E6/E7 mRNA in screening for CIN2+, aiming to provide a new marker for earlier clinical diagnosis of cervical cancer...
May 2024: Oncology Letters
https://read.qxmd.com/read/38572064/secondary-hematological-malignancies-in-patients-with-sarcoma-a-single%C3%A2-center-retrospective-study
#48
JOURNAL ARTICLE
Yoon Jung Jang, Hong Kyu Jeong, Chang-Bae Kong, Won Seok Song, Wan Hyeong Cho, Dae Geun Jeon, Heyjin Kim, Sung Hyun Yang, Im Il Na, Hyo-Rak Lee, Hye Jin Kang
The present retrospective study investigated the clinical features and prognosis of secondary hematological malignancies (SHMs) in patients with sarcoma at Korea Cancer Center Hospital (Seoul, South Korea). Patients who had been diagnosed with SHMs after having received treatment for sarcoma between January 2000 and May 2023 were enrolled. Clinical data were collected from the patients' medical records. Clinical characteristics were analyzed, including SHM incidence, type and prognosis. Of 2,953 patients with sarcoma, 18 (0...
May 2024: Oncology Letters
https://read.qxmd.com/read/38572063/the-expression-of-trefoil-factor-family-member-2-in-increased-at-an-acidic-ph
#49
JOURNAL ARTICLE
Yui Masumoto, Suzuka Matsuo, Natsuno Kinjou, Yuka Narieda, Morimasa Wada, Kyoko Fujimoto
Trefoil factor family member 2 ( Tff2 ) is significantly involved in intestinal tumor growth in Apc Min/+ mice, which can be used as a human colon cancer model. TFF2 , which encodes TFF2 (spasmolytic protein 1) is highly expressed in human cancer tissues, including the pancreas, colon and bile ducts, as well as in normal gastric and duodenum tissues. By contrast, TFF2 exhibits low expression levels in other normal tissues, including the small and large intestine. Furthermore, TFF2 expression has not been detected in DLD-1 cells, a cell line derived from human colon cancer...
May 2024: Oncology Letters
https://read.qxmd.com/read/38572062/-retracted-serum-mir%C3%A2-338%C3%A2-5p-has-potential-for-use-as-a-tumor-marker-for-retinoblastoma
#50
Peng Zhou, Xuemin Li
[This retracts the article DOI: 10.3892/ol.2019.10331.].
May 2024: Oncology Letters
https://read.qxmd.com/read/38572061/effect-of-different-preoperative-nutritional-treatments-on-postoperative-recovery-and-clinical-outcomes-in-patients-with-gastric-cancer-and-early-gastric-outlet-obstruction
#51
JOURNAL ARTICLE
Caixia Wang, Dameng Yang
Patients with gastric cancer and early gastric outlet obstruction often experience malnutrition and require various nutritional support strategies. This study aimed to evaluate the impact of different preoperative nutritional treatments on their postoperative recovery and prognosis. The present retrospective study collected data from 467 patients with gastric cancer and early gastric outlet obstruction who underwent surgery at Harbin Medical University Cancer Hospital (Harbin, China) between January 2016 and December 2018...
May 2024: Oncology Letters
https://read.qxmd.com/read/38572060/clinicopathological-features-of-cholangiolocarcinoma-and-impact-of-tumor-heterogeneity-on-prognosis-a-single-institution-retrospective-study
#52
JOURNAL ARTICLE
Hiroaki Sugita, Shinichi Nakanuma, Ryosuke Gabata, Tomokazu Tokoro, Ryohei Takei, Mitsuyoshi Okazaki, Kaichiro Kato, Satoshi Takada, Isamu Makino, Kazuto Kozaka, Kenichi Harada, Shintaro Yagi
Cholangiolocarcinoma (CLC) is an extremely rare tumor classified as a subtype of small duct-type intrahepatic cholangiocarcinoma (iCCA). There are few detailed reports on CLC and the prognostic impact of tumor heterogeneity is not clear. Between April 2006 and June 2022, of the 774 primary liver cancer resection cases who presented at Kanazawa University Hospital, 14 patients were pathologically diagnosed with CLC through immunohistochemical analysis of their molecular and biological features. Clinicopathological features and prognoses were evaluated retrospectively...
May 2024: Oncology Letters
https://read.qxmd.com/read/38572059/p160-nuclear-receptor-coactivator-family-members-and-their-role-in-rare-fusion%C3%A2-driven-neoplasms-review
#53
REVIEW
Danilo Segovia, Polona Safaric Tepes
Gene fusions with translocations involving nuclear receptor coactivators (NCoAs) are relatively common among fusion-driven malignancies. NCoAs are essential mediators of environmental cues and can modulate the transcription of downstream target genes upon binding to activated nuclear receptors. Therefore, fusion proteins containing NCoAs can become strong oncogenic drivers, affecting the cell transcriptional profile. These tumors show a strong dependency on the fusion oncogene; therefore, the direct pharmacological targeting of the fusion protein becomes an attractive strategy for therapy...
May 2024: Oncology Letters
https://read.qxmd.com/read/38549804/misdiagnosis-of-multiple-myeloma-as-postoperative-bone-metastasis-of-rectal-cancer-a-case-report-and-literature-review
#54
Yuanqi Huang, Zhengquan Chen, Kunming Wen
Multiple myeloma (MM) and bone metastases are both common malignant tumors of the skeleton that share similar clinical manifestations and radiological features. The development of MM following rectal cancer surgery is relatively rare in clinical practice and is easily misdiagnosed as bone metastasis. The present study reported on a patient with MM and postoperative rectal cancer. A 65-year-old man had been diagnosed with low rectal cancer (poorly differentiated, T3N1M0) 10 years prior and underwent curative treatment at that time...
May 2024: Oncology Letters
https://read.qxmd.com/read/38549803/characteristics-and-prognostic-value-of-gut-microbiota-in-follicular-lymphoma
#55
JOURNAL ARTICLE
Zhuo-Fan Xu, Danqing Zhao, Chong Wei, Wei Wang, Yan Zhang, Wei Zhang, Daobin Zhou
The pathogenesis and progression of follicular lymphoma (FL) depends on immune evasion mechanisms. The gut microbiota has been reported to be associated with the development and outcome of several human diseases by modulating host immunity. Thus, the present study investigated the characteristics and prognostic value of the gut microbiota in FL. Fecal samples from treatment-naïve patients with FL (n=28) and healthy controls (n=18) were prospectively collected. The gut microbiota diversity and composition were examined by 16S ribosomal RNA sequencing...
May 2024: Oncology Letters
https://read.qxmd.com/read/38549802/use-of-ultra-high-performance-liquid-chromatography-high-resolution-mass-spectroscopy-to-profile-the-metabolites-from-the-serum-of-patients-with-breast-cancer
#56
JOURNAL ARTICLE
Qinqin Zhang, Rongzhao Lu, Ying Wu, Yong Hong, Ningxia Wang, Cunchuan Wang
Breast cancer (BC) is the most common type of malignancy and the leading cause of cancer-associated mortality in women worldwide. As such, assessing the metabolic changes during human breast carcinogenesis is key for developing disease prevention methods and treatment. In the present study, non-targeted metabolomics with chemometrics based on ultra-high performance liquid chromatography-high-resolution mass spectrometry were performed to assess differences in serum metabolite patterns between patients with BC and healthy individuals...
May 2024: Oncology Letters
https://read.qxmd.com/read/38549801/pycr1-regulates-trail%C3%A2-resistance-in-non%C3%A2-small-cell-lung-cancer-cells-by-regulating-the-redistribution-of-death-receptors
#57
JOURNAL ARTICLE
Chengcheng You, Jinlan He, Chunyu Cao, Deqiao Sheng, Lin Wang, Zhixian Huang, Xiaoling Zhang, Changjun Yi, Yingming Sun, Yiling Huang
Although recombinant human TNF-related apoptosis-inducing ligand (TRAIL) protein exhibits antitumor activity in a number of lung and liver cancer cells and tumor-bearing animals, TRAIL resistance has substantially restricted its clinical application. Pyrroline-5-carboxylate reductase 1 (PYCR1) is a key enzyme in the regulation of proline synthesis. PYCR1 is highly expressed in various types of malignant tumor, in which it has been implicated in 5-fluorouracil resistance. However, the possible relationship between PYCR1 and TRAIL resistance remains unclear...
May 2024: Oncology Letters
https://read.qxmd.com/read/38516689/clinical-role-of-the-long-non%C3%A2-coding-rna-egfr%C3%A2-as1-in-patients-with-cancer-a-systematic-review-and-meta%C3%A2-analysis
#58
JOURNAL ARTICLE
Lei Zhu, Jie Zhang, Hongxia Zhou, Guanqi Zhang, Bin Wang, Haolong Qi
The novel long non-coding RNA, EGFR-AS1, is expressed in various types of solid tumour, and its oncogenic role has been fully identified. In the present study, several articles were screened following an electronic search of the PubMed database. In total, 8 studies were included in the present systematic review. For each analysis indicator risk ratios (RRs) with 95% confidence intervals (CIs) or hazard ratios (HRs) with standard errors and 95% CIs were estimated using Review Manager 5.3. The pooled RR of high EGFR-AS1 expression among patients with or without vascular invasion was 1...
May 2024: Oncology Letters
https://read.qxmd.com/read/38516688/development-and-external-validation-of-a-novel-score-for-predicting-postoperative-30%C3%A2-day-mortality-in-tumor-craniotomy-patients-a-cross%C3%A2-sectional-diagnostic-study
#59
JOURNAL ARTICLE
Yufei Liu, Haofei Hu, Yong Han, Zongyang Li, Jihu Yang, Xiejun Zhang, Lei Chen, Fanfan Chen, Weiping Li, Guodong Huang
The identification of patients with craniotomy at high risk for postoperative 30-day mortality may contribute to achieving targeted delivery of interventions. The present study aimed to develop a personalized nomogram and scoring system for predicting the risk of postoperative 30-day mortality in such patients. In this retrospective cross-sectional study, 18,642 patients with craniotomy were stratified into a training cohort (n=7,800; year of surgery, 2012-2013) and an external validation cohort (n=10,842; year of surgery, 2014-2015)...
May 2024: Oncology Letters
https://read.qxmd.com/read/38516687/effectiveness-and-safety-of-neoadjuvant-apatinib-in-combination-with-capecitabine-and-oxaliplatin-for-the-therapy-of-locally-advanced-colorectal-cancer-a-retrospective-study
#60
JOURNAL ARTICLE
Tao Zhang, Xinyu Peng, Gang Li, Liqi Yan, Aimin Zhang, Xiongjie Jia
The goal of the present study was to appraise the efficacy and safety of neoadjuvant apatinib in combination with capecitabine and oxaliplatin (XELOX) in patients with locally advanced colorectal cancer (CRC), as relevant data on its usage in this setting are lacking. A retrospective analysis was implemented on 100 patients with locally advanced CRC who received either neoadjuvant apatinib in combination with XELOX (N=50) or neoadjuvant XELOX alone (N=50). Radiological response and pathological complete response rates were evaluated...
May 2024: Oncology Letters
journal
journal
43024
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.